After-Hours Movers 7/20: JDAS, USPH, PKG, LM, MDRX Higher; IDIX, FWRD, WERN, CACH, BMS Lower
Up)
JDA Software (Nasdaq: JDAS) 22.8% HIGHER; reports Q2 EPS of $0.47, 17 cents better than the analyst estimate of $0.30. Revenue for the quarter was $99.5 million, versus the consensus of $86.2 million.
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) 22% LOWER; reports Q2 loss of $0.28, 3 cents below than the analyst estimate of ($0.25). Revenue for the quarter was $2.45 million, versus the consensus of $3.39 million.
U.S. Physical Therapy, Inc. (NASDAQ: USPH) 15% HIGHER; reports preliminary Q2 EPS of $0.31 vs. consensus of $0.24. Revenues were $51.79 million vs. $49.35 million consensus. Raises its FY09 EPS guidance from $0.84-$0.90 to $0.93-$0.98, which compares to the Street estimate of $0.90.
Packaging Corporation of America (NYSE: PKG) 12.3% HIGHER; reports Q2 EPS of $0.28, ex-items, 12 cents better than the analyst estimate of $0.16. Revenue for the quarter was $549.4 million, versus the consensus of $535.21 million. Sees Q3 EPS of about $0.24, which compares to the Street estimate of $0.12.
Boston Scientific Corporatio-n (NYSE: BSX) 7% HIGHER; reports Q2 EPS of $0.20, ex-items, 7 cents better than the analyst estimate of $0.13. Revenue for the quarter was $2.07 billion, versus the consensus of $2.05 billion. Narrows its FY09 non-GAAP EPS guidance to $0.82-$0.86 on sales of $8.1-$8.4 billion. The Street is currently expecting FY09 EPS and sales of $0.57 and $8.17 billion, respectively.
Forward Air (Nasdaq: FWRD) 6.8% LOWER; reports Q2 EPS of $0.10, 1 cent better than the analyst estimate of $0.09. Revenue for the quarter was $99.7 million, versus the consensus of $105.68 million. “Assuming no further material deterioration in the environment, for the third quarter of 2009, we anticipate a year-over-year decline in revenue in the range of 15 to 20% and expect income per diluted share to be between $0.08 and $0.14 per share.” (Q3 EPS consensus is $0.17)
Legg Mason (NYSE: LM) 6.6% HIGHER; reports Q1 EPS of $0.35, versus the analyst estimate of $0.22 and compared to a loss of $0.26 in the same quarter last year. Cash EPS for the quarter were $0.65 Revenue for the quarter was $613.1 million, versus the consensus of $612.34 million. AUM increased 4% to $656.9 billion compared with $632.4 billion in the fourth fiscal quarter of 2009 primarily driven by market appreciation of 9%, offset in part by reduced client outflows. AUM decreased 29% from $922.8 billion in the first fiscal quarter of 2009. Click here for the full report.
Werner Enterprises, Inc. (NASDAQ: WERN) 5.4% LOWER; reports Q2 EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter was $403.1 million, versus the consensus of $435.41 million.
Cache, Inc. (Nasdaq: CACH) 5% LOWER; reports Q2 EPS of $0.07, 1 cent better than the analyst estimate of $0.06. Revenue for the quarter was $56.9 million, versus the consensus of $58.64 million. The Company is introducing guidance for the third quarter of fiscal 2009. The Company estimates net sales in the range of $48 million to $50 million, which compares to actual net sales of $58.1 million in fiscal 2008. (Consensus is $51.48M) Loss per share for the third quarter of fiscal 2009 is estimated in the range of ($0.22) to ($0.17) vs. consensus for $0.08 loss.
Bemis Company, Inc. (NYSE: BMS) 2.8% LOWER; is commencing a public offering of 7,500,000 shares of its common stock pursuant to a shelf registration statement on Form S-3 filed today with the SEC. The Company will grant the underwriters an option for 30 days to purchase up to 1,125,000 additional shares of common stock to cover over-allotments, if any. The Company plans to use the net proceeds from the equity offering to fund a portion of the purchase price for its previously announced acquisition of Alcan Packaging Food Americas
ICU Medical, Inc. (Nasdaq: ICUI) 2.2% LOWER; reports Q2 EPS of $0.38, 3 cents better than the analyst estimate of $0.35. Revenue for the quarter was $53.4 million, versus the consensus of $53.03 million. Boosts FY09 revenue guidance to $220M to $230M from $215M to $225M. Raises FY09 EPS guidance to $1.62 to $1.71 versus previous guidance of $1.58 to $1.70.
Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX) 1.9% HIGHER; reports Q4 EPS of $0.16, 1 cent better than the analyst estimate of $0.15. Revenue for the quarter was $166.2 million, versus the consensus of $160.03 million.
Texas Instruments (NYSE: TXN) 1% LOWER; reports Q2 EPS of $0.20, 2 cents better than the analyst estimate of $0.18. Revenue for the quarter was $2.46 billion, versus the consensus of $2.41 billion. Sees Q3 EPS of $0.29-$0.39, versus the consensus of $0.27 and revs of $2.5-$2.8 billion, versus the Street estimate of $2.52 billion.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) 22% LOWER; reports Q2 loss of $0.28, 3 cents below than the analyst estimate of ($0.25). Revenue for the quarter was $2.45 million, versus the consensus of $3.39 million.
U.S. Physical Therapy, Inc. (NASDAQ: USPH) 15% HIGHER; reports preliminary Q2 EPS of $0.31 vs. consensus of $0.24. Revenues were $51.79 million vs. $49.35 million consensus. Raises its FY09 EPS guidance from $0.84-$0.90 to $0.93-$0.98, which compares to the Street estimate of $0.90.
Packaging Corporation of America (NYSE: PKG) 12.3% HIGHER; reports Q2 EPS of $0.28, ex-items, 12 cents better than the analyst estimate of $0.16. Revenue for the quarter was $549.4 million, versus the consensus of $535.21 million. Sees Q3 EPS of about $0.24, which compares to the Street estimate of $0.12.
Boston Scientific Corporatio-n (NYSE: BSX) 7% HIGHER; reports Q2 EPS of $0.20, ex-items, 7 cents better than the analyst estimate of $0.13. Revenue for the quarter was $2.07 billion, versus the consensus of $2.05 billion. Narrows its FY09 non-GAAP EPS guidance to $0.82-$0.86 on sales of $8.1-$8.4 billion. The Street is currently expecting FY09 EPS and sales of $0.57 and $8.17 billion, respectively.
Forward Air (Nasdaq: FWRD) 6.8% LOWER; reports Q2 EPS of $0.10, 1 cent better than the analyst estimate of $0.09. Revenue for the quarter was $99.7 million, versus the consensus of $105.68 million. “Assuming no further material deterioration in the environment, for the third quarter of 2009, we anticipate a year-over-year decline in revenue in the range of 15 to 20% and expect income per diluted share to be between $0.08 and $0.14 per share.” (Q3 EPS consensus is $0.17)
Legg Mason (NYSE: LM) 6.6% HIGHER; reports Q1 EPS of $0.35, versus the analyst estimate of $0.22 and compared to a loss of $0.26 in the same quarter last year. Cash EPS for the quarter were $0.65 Revenue for the quarter was $613.1 million, versus the consensus of $612.34 million. AUM increased 4% to $656.9 billion compared with $632.4 billion in the fourth fiscal quarter of 2009 primarily driven by market appreciation of 9%, offset in part by reduced client outflows. AUM decreased 29% from $922.8 billion in the first fiscal quarter of 2009. Click here for the full report.
Werner Enterprises, Inc. (NASDAQ: WERN) 5.4% LOWER; reports Q2 EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter was $403.1 million, versus the consensus of $435.41 million.
Cache, Inc. (Nasdaq: CACH) 5% LOWER; reports Q2 EPS of $0.07, 1 cent better than the analyst estimate of $0.06. Revenue for the quarter was $56.9 million, versus the consensus of $58.64 million. The Company is introducing guidance for the third quarter of fiscal 2009. The Company estimates net sales in the range of $48 million to $50 million, which compares to actual net sales of $58.1 million in fiscal 2008. (Consensus is $51.48M) Loss per share for the third quarter of fiscal 2009 is estimated in the range of ($0.22) to ($0.17) vs. consensus for $0.08 loss.
Bemis Company, Inc. (NYSE: BMS) 2.8% LOWER; is commencing a public offering of 7,500,000 shares of its common stock pursuant to a shelf registration statement on Form S-3 filed today with the SEC. The Company will grant the underwriters an option for 30 days to purchase up to 1,125,000 additional shares of common stock to cover over-allotments, if any. The Company plans to use the net proceeds from the equity offering to fund a portion of the purchase price for its previously announced acquisition of Alcan Packaging Food Americas
ICU Medical, Inc. (Nasdaq: ICUI) 2.2% LOWER; reports Q2 EPS of $0.38, 3 cents better than the analyst estimate of $0.35. Revenue for the quarter was $53.4 million, versus the consensus of $53.03 million. Boosts FY09 revenue guidance to $220M to $230M from $215M to $225M. Raises FY09 EPS guidance to $1.62 to $1.71 versus previous guidance of $1.58 to $1.70.
Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX) 1.9% HIGHER; reports Q4 EPS of $0.16, 1 cent better than the analyst estimate of $0.15. Revenue for the quarter was $166.2 million, versus the consensus of $160.03 million.
Texas Instruments (NYSE: TXN) 1% LOWER; reports Q2 EPS of $0.20, 2 cents better than the analyst estimate of $0.18. Revenue for the quarter was $2.46 billion, versus the consensus of $2.41 billion. Sees Q3 EPS of $0.29-$0.39, versus the consensus of $0.27 and revs of $2.5-$2.8 billion, versus the Street estimate of $2.52 billion.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
You May Also Be Interested In
- Pre-Open Movers 5/25: (BLOX) (FRO) (QSFT) Higher; (TLB) (ROSG) (DCTH) Lower (more...)
- Notable Mergers and Acquisitions of the Day 05/22: (GOOG)/(MMI) (BX) (BNHN) (RRD)/(EDGR)
- Notable 52-Week Highs and Lows of the Day 05/24: (LCC) (PETM) (DUK) High; (NTAP) (RIMM) (CPRX) Low
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
